Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2022-11-24 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report from Medicure Inc. reporting financial results for the quarter ended September 30, 2022. It includes comprehensive financial data such as revenue, net income, EBITDA, and detailed interim consolidated financial statements (statements of financial position and net income). The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarterly data) indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or press release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2022
2022-11-24 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed unaudited condensed consolidated interim financial statements for Medicure Inc. for the three and nine months ended September 30, 2022. It includes statements of financial position, net income, comprehensive income, and changes in equity, all typical components of an interim or quarterly financial report. The presence of specific fiscal period dates (three and nine months ended September 30, 2022) and substantive financial data confirms this is a financial report for a period shorter than a full fiscal year. The document is approximately 15,000 characters long, indicating it is the report itself, not just an announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2022
2022-11-24 English
Interim MD&A - English.pdf
Regulatory Filings
2022-11-24 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The document is primarily an officer certification letter, not containing actual financial data or the interim report itself. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (2996 characters), and it is a certification rather than a full report or announcement. Therefore, the correct classification is Regulatory Filings (RNS).
2022-11-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2022. The document is primarily an officer certification letter and does not contain actual financial data or substantive financial analysis. It references the interim filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3008 characters), consistent with a certification letter rather than a full report.
2022-11-24 English
News release - English.pdf
Regulatory Filings
2022-11-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.